TrialNeuro-oncology2010

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

Sandeep Kunwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.